Nov 5 (Reuters) - MGC Pharmaceuticals Ltd (MXC) :
- MGC PHARMACEUTICALS LTD - ANNOUNCES COMPLETION OF ARTEMICTM PHASE II CLINICAL TRIAL ON COVID-19 INFECTED PATIENTS
- MGC PHARMACEUTICALS LTD - NOW DESIGNING PROTOCOLS AND PARAMETERS FOR NEXT PHASE OF INTERNATIONAL MULTI-CENTRE CLINICAL TRIAL
News: MXC MGC Pharmaceuticals Announces Completion Of Artemictm Phase Ii Clinical Trial
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.20M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 37.0¢ | $1.045K | 2.801K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1654 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 164 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
| RGT (ASX) Chart |